Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1

Conditions

Leukemia, Myeloid, Acute 358Precursor Cell Lymphoblastic Leukemia-Lymphoma 164Leukemia 160Lymphoma 109Myelodysplastic Syndromes 74Lymphoma, Non-Hodgkin 66Lymphoma, Large B-Cell, Diffuse 61Lymphoma, Mantle-Cell 59Burkitt Lymphoma 58Recurrence 56Congenital Abnormalities 44Leukemia, Monocytic, Acute 39Lymphoma, Follicular 37Hodgkin Disease 35Leukemia, Myelomonocytic, Acute 34Leukemia, Erythroblastic, Acute 34Leukemia, Megakaryoblastic, Acute 32Blast Crisis 29Lymphoma, Large-Cell, Immunoblastic 27Leukemia, Myelomonocytic, Chronic 26Leukemia, Lymphocytic, Chronic, B-Cell 26Leukemia, Biphenotypic, Acute 26Leukemia, Myelogenous, Chronic, BCR-ABL Positive 24Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 19Lymphoma, B-Cell, Marginal Zone 19Anemia, Refractory, with Excess of Blasts 19Myeloproliferative Disorders 17Lymphoma, B-Cell 17Leukemia, Myeloid, Accelerated Phase 16Neoplasm, Residual 15

Interventions

venetoclax 1pevonedistat 1Watchful Waiting 1Imatinib Mesylate 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Dasatinib 1Cytarabine 1Cladribine 1Azacitidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Hypereosinophilic Syndrome × Cytarabine × Clear all
NCT00483067 2012-08-02

2-Chlorodeoxyadenosine and Cytarabine in Patients With Idiopathic Hypereosinophilic Syndrome (HES)

M.D. Anderson Cancer Center

Phase 2 Completed
13 enrolled
MyeloidOther hematologic neoplasm

Leukemia, Hypereosinophilic Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡